The FDA involves Rybelsus to hold a black box warning—essentially the most really serious style of warning—about the chance of thyroid C-cell tumors. This warning stems from animal reports exhibiting that semaglutide and connected remedies brought on thyroid tumors, like most cancers, in rodents.